-
1 Comment
Bausch Health Companies Inc is currently in a long term uptrend where the price is trading 9.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Bausch Health Companies Inc's total revenue sank by 0.5% to $2B since the same quarter in the previous year.
Its net income has increased by 89.9% to $-153M since the same quarter in the previous year.
Finally, its free cash flow grew by 108.1% to $310M since the same quarter in the previous year.
Based on the above factors, Bausch Health Companies Inc gets an overall score of 4/5.
None
Here's how to backtest a trading strategy or backtest a portfolio for BHC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
